Myriad Genetics, Inc. (NASDAQ:MYGN) Receives $21.82 Average Price Target from Analysts
Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have been given an average recommendation of “Hold” by the fifteen brokerages that are presently covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a sell recommendation, seven have issued a hold recommendation and five have issued a buy recommendation on […]
Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have been given an average recommendation of “Hold” by the fifteen brokerages that are presently covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a sell recommendation, seven have issued a hold recommendation and five have issued a buy recommendation on […]
